News | June 03, 2021
Sun Pharma and Ferring Pharmaceuticals to introducing CARITEC in India
Sun Pharma is granted rights for co-marketing of the drug in India in the private market under the brand name CARITEC
Sun Pharma is granted rights for co-marketing of the drug in India in the private market under the brand name CARITEC
Revenues from operations for FY21 stood at Rs. 202.38 crore as compared to 167.27 crore, up by 21%
The company has posted net profit of Rs.147.78 crores for the 12 months period ended March 31, 2021
The company reported total income of Rs.24774.63 crores during the 12 months period ended March 31, 2021
Adjusted PAT declined 18.8% YoY
India formulations business grew 14.7% YoY with recovery in industry growth from COVID-19 impact
US revenues were sequentially stable at US$370mn with steady performance in the specialty portfolio
The company has posted net profit of Rs.1140.01 crores during FY 2020-21
It posted net profit of Rs.60.96 crores for the 12 months period ended March 31, 2021
Cadila Healthcare has reported total income of Rs.15139.4 crores FY 2020-21
Subscribe To Our Newsletter & Stay Updated
